Learn how to successfully co-manage TED patients with an oculoplastic surgeon. Attendees will learn how to manage mild TED, and what current treatments are for moderate and severe TED, including surgical management and radiotherapy.

Almost 1200 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• OMG How did you get Dr Douglas?? He is THE GUY for TED in California!!!!!

• Thank you! Very knowledgeable lecturer and easy to follow with very current information.

• Thank you for providing this CE. This speaker was great for providing the information about the new monoclonal treatment as well as surgeries.

• Great presentation , he kept the talk interesting and informative.

• This was an awesome presentation. Best CE in a long time. Speaker is excellent.

• Your Continuing Education is always so informative. Every time I participate in one, I feel my knowledge base has increased!That's with with any subject that I have participated with Woo University. Thank you for these opportunities.

• Fantastic talk. Hats off to the speaker for not only covering what is becoming main stream treatment, but also the unique approaches he uses to customize treatment for his patients.

• Dr. Douglas' presentation extremely well done, logically presented. Wish I could watch again.

Speaker: Raymond Douglas, MD, PhD

Moderator: Dr. Elise Kramer

COPE ID: 87147-SD

Category: Systemic/Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Horizon Therapeutics for providing an unrestricted educational grant to support this event.

This lecture will outline and describe the current understanding of thyroid eye disease (TED) and its interrelation with Graves’ Disease. It will describe incidence, risk factors, and associated systemic signs, symptoms, and pathophysiology including Rundle’s curve. We will discuss treatment options for TED including the recent FDA approval of Teprotumumab, its clinical trials, study endpoints, and adverse reactions. Masquerading ocular findings that may be early signs of TED will be described as well as lab testing that can help with the early detection of TED will be discussed. Doctors have a knowledge need for this practice gap which means having the knowledge of how to detect, diagnose, and treat TED in an integrated, multidisciplinary method.

Almost 1000 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• WOW FANTASTIC HIGH YIELD LECTURE w/ clinical cases, pathophysiology, detailed !!

• Great speaker and this series has helped educate me on this condition so i hopefully will be more aware and able to help my patients faster.

• This was the best talk I have ever heard on this topic.

• Appreciated the distinct talk about antibodies rather than just thyroid dx.

• I learned about ordering the TSI Thyroid Stimulating Immunoglobulin serum test. Tepezza is an infusion. Thank you for an interesting lecture.

• Pearls in TED will help pt care better. Thank you Dr Lang and Dr Woo.

• Learned a lot about the new things surrounding TED!

• Outstanding especially with use of interaction!

Speaker: Jacob Lang, OD

Moderator: Dr. Jennifer Stewart

COPE ID: 80761-SD

Category: Systemic/Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Horizon Therapeutics for providing an unrestricted educational grant to support this event.

Join Woo U for this two-hour course on Thyroid Eye Disease. This course unravels and illustrates the close association between the eye and thyroid dysfunction. Clinical features, laboratory testing, clinical examination, and therapeutic options will be reviewed. The ocular manifestations and management of this condition will be discussed.

Over 1000 attended our event and we received amazing feedback!

Feedback from anonymous:

• Wow! such great education on All things thyroid.

• Brilliant! Always enjoy Dr Caldwell's presentations.

• Absolute mastery of this subject. Excellent speaker!

• Learned a lot about TED and will now be on guard to watch for it.

• Great presentation and clearly identified clinical significance.

• Wow, speaker was very effective and concise!

• Great lecture, applicable, pulled in functional health tx, treating whole patient inflammation and targeting with Tempezza.

• I ended up wishing that he would speak longer rather than being glad the presentation was over.

Speaker: Gregory Caldwell, OD

Moderator: Dr. Jennifer Stewart

COPE ID: 82803-SD

Category: Systemic/Ocular Disease

This event is COPE approved for 2 hours of CE credit.

Thank you to Horizon Therapeutics for providing an unrestricted educational grant to support this event.